复星医药:2024年公司通过处置资产回笼金额超过20亿元人民币
Mei Ri Jing Ji Xin Wen·2025-08-12 11:12

Core Viewpoint - The company is focusing on divesting non-core businesses and optimizing its asset structure to enhance cash flow, with plans to recover over 2 billion RMB through asset disposals in 2024 [2]. Group 1: Non-Core Business Strategy - The company plans to exit non-core businesses, which will be determined by market conditions and business planning to ensure strategic focus and shareholder interests [2]. - The scale of the non-core investments and the timeline for exiting these investments have not been specified, indicating a flexible approach based on various factors [2]. Group 2: Strategic Investment - The strategic investment by Fosun Health in Foshan Zhanxi City Investment is still in progress, with both parties actively working on the implementation [2].